IGC

Latest SEC Filings & News for IGC

3 most recent filings and news items mentioning IGC. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/IGC/news?limit=20"

Pull IGC filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
OtherJul 13, 2026Neutral

IGC Pharma presents illustrative valuations for Alzheimer's treatment IGC-AD1

IGC Pharma disclosed a presentation detailing potential stock value scenarios for Alzheimer's drug IGC-AD1. The company anticipates potential valuations ranging from $300 million to $4 billion contingent upon successful clinical development and regulatory milestones.

View filing at SEC.gov →
OfferingJul 6, 2026Neutral

IGC Pharma enters agreement to sell shares at $0.27 per share

IGC Pharma entered into a Stock Purchase Agreement to issue shares to a Purchaser for $0.27 per share. The transaction is scheduled to close on June 30, 2026, and will be settled through the cancellation of existing debt.

View filing at SEC.gov →
OtherJun 8, 2026Neutral

IGC Pharma files exhibit document with SEC

IGC Pharma submitted an exhibit filing to the SEC. The document lacks substantive business information for market analysis.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.